Literature DB >> 21097670

Epithin/PRSS14 proteolytically regulates angiopoietin receptor Tie2 during transendothelial migration.

Chungho Kim1, Hyo Seon Lee, Deokjae Lee, Sang Don Lee, Eun-Gyung Cho, Soo Jung Yang, Sang Bum Kim, Dongeun Park, Moon Gyo Kim.   

Abstract

Epithin/PRSS14, a type II transmembrane serine protease, is involved in normal epithelial development and tumor progression. Here we report, as an interacting substrate of epithin, a receptor tyrosine kinase Tie2 that is well known for important roles in the vessel stability. Epithin interacts with and degrades the Tie2 extracellular portion that contains the ligand-binding domain. Epithin is located in the neighbor of Tie2-expressing vessels in normal tissue. Furthermore, epithin can cleave and degrade Tie2 not only in the same cell but also from neighboring cells nearby, resulting in the degradation of the Tie2 ectodomain. The remaining Tie2 fragment was highly phosphorylated and was able to recruit a downstream effector, phosphatidylinositol 3-kinase. Knocking down epithin expression using short hairpin RNA in thymoma cell severely impaired the migration through endothelial cells that show the actin rearrangement during the process. The diminution of epithin protein expression in 4T1 breast cancer cells caused the significant decrease in the number of transendothelial migrating cells in vitro as well as in those of metastasizing tumor nodules in vivo, Therefore, we propose that epithin, which regulates endothelial Tie2 functions, plays a critical role in the fine tuning of transendothelial migration for normal and cancer cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21097670     DOI: 10.1182/blood-2010-03-275289

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Filamin A is required in injured axons for HDAC5 activity and axon regeneration.

Authors:  Yongcheol Cho; Dongeun Park; Valeria Cavalli
Journal:  J Biol Chem       Date:  2015-07-08       Impact factor: 5.157

2.  ADAM12: a genetic modifier of preclinical peripheral arterial disease.

Authors:  Ayotunde O Dokun; Lingdan Chen; Mitsuharu Okutsu; Charles R Farber; Surovi Hazarika; W Schuyler Jones; Damian Craig; Douglas A Marchuk; R John Lye; Svati H Shah; Brian H Annex
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-10       Impact factor: 4.733

3.  Overexpression of matriptase correlates with poor prognosis in esophageal squamous cell carcinoma.

Authors:  Sang Yun Ha; Ki Yeon Kim; Nam Kyung Lee; Moon Gyo Kim; Seok-Hyung Kim
Journal:  Virchows Arch       Date:  2013-11-19       Impact factor: 4.064

4.  Diversity of matriptase expression level and function in breast cancer.

Authors:  Arkadiusz Welman; Duncan Sproul; Peter Mullen; Morwenna Muir; Andrew R Kinnaird; David J Harrison; Dana Faratian; Valerie G Brunton; Margaret C Frame
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

5.  Impact of suppression of tumorigenicity 14 (ST14)/serine protease 14 (Prss14) expression analysis on the prognosis and management of estrogen receptor negative breast cancer.

Authors:  Sauryang Kim; Jae Woong Yang; Chungho Kim; Moon Gyo Kim
Journal:  Oncotarget       Date:  2016-06-07

6.  Proteolytic cleavages in the extracellular domain of receptor tyrosine kinases by membrane-associated serine proteases.

Authors:  Li-Mei Chen; Karl X Chai
Journal:  Oncotarget       Date:  2017-04-10

7.  Intramembrane proteolysis of an extracellular serine protease, epithin/PRSS14, enables its intracellular nuclear function.

Authors:  Youngkyung Cho; Sang Bum Kim; Jiyoon Kim; An Vuong Quynh Pham; Min Ji Yoon; Jeong Hwan Park; Ki-Tae Hwang; Dongeun Park; Yongcheol Cho; Moon Gyo Kim; Chungho Kim
Journal:  BMC Biol       Date:  2020-06-03       Impact factor: 7.431

8.  Targeting metastatic breast cancer with peptide epitopes derived from autocatalytic loop of Prss14/ST14 membrane serine protease and with monoclonal antibodies.

Authors:  Ki Yeon Kim; Minsang Yoon; Youngkyung Cho; Kwang-Hoon Lee; Sora Park; Se-Ra Lee; So-Young Choi; Deokjae Lee; Chansik Yang; Eun Hye Cho; Sangjun Davie Jeon; Seok-Hyung Kim; Chungho Kim; Moon Gyo Kim
Journal:  J Exp Clin Cancer Res       Date:  2019-08-19

9.  Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation.

Authors:  Roman Szabo; Katiuchia Uzzun Sales; Peter Kosa; Natalia A Shylo; Sine Godiksen; Karina K Hansen; Stine Friis; J Silvio Gutkind; Lotte K Vogel; Edith Hummler; Eric Camerer; Thomas H Bugge
Journal:  PLoS Genet       Date:  2012-08-30       Impact factor: 5.917

10.  Regulation of feto-maternal barrier by matriptase- and PAR-2-mediated signaling is required for placental morphogenesis and mouse embryonic survival.

Authors:  Roman Szabo; Diane E Peters; Peter Kosa; Eric Camerer; Thomas H Bugge
Journal:  PLoS Genet       Date:  2014-07-31       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.